ArticleOncotarget2017

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.

Rhiannon Coulson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.